226 related articles for article (PubMed ID: 25455739)
21. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro.
Mckinnirey F; Herbert B; Vesey G; McCracken S
Sci Rep; 2021 Jun; 11(1):12454. PubMed ID: 34127731
[TBL] [Abstract][Full Text] [Related]
22. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
23. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo Ikkβ ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis.
Kizilay Mancini O; Huynh DN; Menard L; Shum-Tim D; Ong H; Marleau S; Colmegna I; Servant MJ
Cardiovasc Res; 2021 Feb; 117(3):756-766. PubMed ID: 32339220
[TBL] [Abstract][Full Text] [Related]
25. Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells.
Selleri S; Dieng MM; Nicoletti S; Louis I; Beausejour C; Le Deist F; Haddad E
Stem Cells Dev; 2013 Apr; 22(7):1063-75. PubMed ID: 23167734
[TBL] [Abstract][Full Text] [Related]
26. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
27. Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion cultures.
Grau-Vorster M; Rodríguez L; Torrents-Zapata S; Vivas D; Codinach M; Blanco M; Oliver-Vila I; García-López J; Vives J
Cytotherapy; 2019 Jan; 21(1):32-40. PubMed ID: 30447901
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro.
Kiernan CH; Hoogduijn MJ; Franquesa M; Wolvius EB; Brama PAJ; Farrell E
Cytotherapy; 2016 Aug; 18(8):957-969. PubMed ID: 27288309
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1).
Nicotra T; Desnos A; Halimi J; Antonot H; Reppel L; Belmas T; Freton A; Stranieri F; Mebarki M; Larghero J; Cras A; Faivre L
Stem Cell Res Ther; 2020 Oct; 11(1):426. PubMed ID: 33004063
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in CD4+ Memory T Cells.
Kiernan CH; Asmawidjaja PS; Fahy N; Witte-Bouma J; Wolvius EB; Brama PAJ; Lubberts E; Farrell E
Tissue Eng Part A; 2020 May; 26(9-10):490-502. PubMed ID: 31797740
[TBL] [Abstract][Full Text] [Related]
31. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease.
Tobin LM; Healy ME; English K; Mahon BP
Clin Exp Immunol; 2013 May; 172(2):333-48. PubMed ID: 23574329
[TBL] [Abstract][Full Text] [Related]
32. A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells.
Hillmann A; Paebst F; Brehm W; Piehler D; Schubert S; Tárnok A; Burk J
PLoS One; 2019; 14(6):e0218949. PubMed ID: 31247035
[TBL] [Abstract][Full Text] [Related]
33. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
34. Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.
Kim J; Breunig MJ; Escalante LE; Bhatia N; Denu RA; Dollar BA; Stein AP; Hanson SE; Naderi N; Radek J; Haughy D; Bloom DD; Assadi-Porter FM; Hematti P
Cytotherapy; 2012 Sep; 14(8):925-35. PubMed ID: 22571381
[TBL] [Abstract][Full Text] [Related]
35. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
36. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
[TBL] [Abstract][Full Text] [Related]
37. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.
Colbath AC; Dow SW; Phillips JN; McIlwraith CW; Goodrich LR
Stem Cells Dev; 2017 Apr; 26(7):503-511. PubMed ID: 27958776
[TBL] [Abstract][Full Text] [Related]
38. Conglomeration of T- and B-Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells.
Porter AP; Pirlot BM; Dyer K; Uwazie CC; Nguyen J; Turner C; Rajan D; Hematti P; Chinnadurai R
Stem Cells; 2022 Dec; 40(12):1134-1148. PubMed ID: 36056823
[TBL] [Abstract][Full Text] [Related]
39. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
Saka Y; Furuhashi K; Katsuno T; Kim H; Ozaki T; Iwasaki K; Haneda M; Sato W; Tsuboi N; Ito Y; Matsuo S; Kobayashi T; Maruyama S
Xenotransplantation; 2011; 18(3):196-208. PubMed ID: 21696449
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
